Literature DB >> 27038170

Overexpression and purification of folded domain of prostate cancer related proteins MSMB and PSA.

Mohini Tiwary1, Nipanshu Agarwal2, Amit Dinda3, Subhash C Yadav4,5.   

Abstract

Overexpression of domains of a human protein using recombinant DNA technology has been challenging because individual domains intend to accumulate as non-soluble aggregate when expressed separately. Studies on identifying right sequences for a domain to be able to fold independently may help understand the folding pattern and underlying protein-engineering events to isolate the functional domains of a protein. In this report, individual domains of prostate cancer related biomarkers; MSMB and PSA were overexpressed in bacterial system and purified in their folded forms using affinity chromatography. The western blotting experiment using domain specific antibodies further confirmed these proteins. The designed nucleotide sequences domains were truncated using fold index software and folding were predicted by phyre2 and I-TASSER software. Other parameters were optimized for their overexpression and purification using Co-NTA affinity chromatography. Purified domains of each protein showed secondary structures such as α + β type for PSA, α/β and β type for the each domains of PSA and MSMB respectively. This is the first report on producing PSA and MSMB individual domains in functional folded forms. This study may help produce the folded domain of many such proteins to be used for better diagnostic purpose.

Entities:  

Keywords:  Domains; Folding; MSMB; PSA; Recombinant protein; Western blotting

Mesh:

Substances:

Year:  2016        PMID: 27038170     DOI: 10.1007/s11033-016-3956-4

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  30 in total

1.  The risk of prostate cancer for men on aspirin, statin or antidiabetic medications.

Authors:  Tobias Nordström; Mark Clements; Robert Karlsson; Jan Adolfsson; Henrik Grönberg
Journal:  Eur J Cancer       Date:  2015-02-23       Impact factor: 9.162

2.  The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling.

Authors:  Konstantin Arnold; Lorenza Bordoli; Jürgen Kopp; Torsten Schwede
Journal:  Bioinformatics       Date:  2005-11-13       Impact factor: 6.937

3.  Expression, purification, and refolding of recombinant collagen alpha1(XI) amino terminal domain splice variants.

Authors:  Lisa R Warner; Christina M Blasick; Raquel J Brown; Julia Thom Oxford
Journal:  Protein Expr Purif       Date:  2006-11-01       Impact factor: 1.650

4.  Protein structure prediction on the Web: a case study using the Phyre server.

Authors:  Lawrence A Kelley; Michael J E Sternberg
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

5.  Overexpression of DEP domain containing mTOR-interacting protein correlates with poor prognosis in differentiated thyroid carcinoma.

Authors:  Lei Pei; Pingfang Xie; Enxiang Zhou; Qian Yang; Yi Luo; Zhonghua Tang
Journal:  Mol Med Rep       Date:  2011-06-02       Impact factor: 2.952

6.  Recombinant expression, in vitro refolding, and biophysical characterization of the N-terminal domain of T1R3 taste receptor.

Authors:  Elodie Maîtrepierre; Maud Sigoillot; Laurence Le Pessot; Loïc Briand
Journal:  Protein Expr Purif       Date:  2012-03-17       Impact factor: 1.650

7.  Expression, purification and structural properties of ABC transporter ABCA4 and its individual domains.

Authors:  Yaroslav Tsybovsky; Krzysztof Palczewski
Journal:  Protein Expr Purif       Date:  2014-02-28       Impact factor: 1.650

Review 8.  MSMB variation and prostate cancer risk: clues towards a possible fungal etiology.

Authors:  Siobhan Sutcliffe; Angelo M De Marzo; Karen S Sfanos; Martin Laurence
Journal:  Prostate       Date:  2014-01-24       Impact factor: 4.104

9.  Recombinant prostate specific antigen inhibits angiogenesis in vitro and in vivo.

Authors:  A H Fortier; J W Holaday; H Liang; C Dey; D K Grella; J Holland-Linn; H Vu; S M Plum; B J Nelson
Journal:  Prostate       Date:  2003-08-01       Impact factor: 4.104

10.  Prostate Cancer Specificity of PCA3 Gene Testing: Examples from Clinical Practice.

Authors:  Leonard S Marks; David G Bostwick
Journal:  Rev Urol       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.